Open AccessLoss of Cystic Fibrosis Transmembrane Conductance Regulator Impairs Lung Endothelial Cell Barrier Function and Increases Susceptibility to Microvascular Damage from Cigarette Smoke
Author(s) -
Brown Mary Beth,
Hunt William R.,
Noe Julie E.,
Rush Natalia I.,
Schweitzer Kelly S.,
Leece Thomas C.,
Moldobaeva Aigul,
Wagner Elizabeth M.,
Dudek Steven M.,
Poirier Christophe,
Presson Robert G.,
Gulbins Erich,
Petrache Irina
Publication year - 2014
Publication title -
pulmonary circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.791
H-Index - 40
ISSN - 2045-8940
DOI - 10.1086/675989
Subject(s) - barrier function , cystic fibrosis transmembrane conductance regulator , medicine , vascular permeability , endothelial stem cell , tight junction , lung , endothelium , cystic fibrosis , endothelial dysfunction , inflammation , microbiology and biotechnology , pathology , endocrinology , immunology , chemistry , biology , in vitro , biochemistry
Abnormal lung microvascular endothelial vascular barrier function may contribute to pulmonary inflammation, such as that occurring during inhalation of cigarette smoke (CS). Cystic fibrosis transmembrane conductance regulator (CFTR), an anion channel expressed in both epithelial and endothelial cells, regulates the organization of tight junctions between epithelial cells and has also been implicated in the transport of sphingosine‐1 phosphate (S1P), a vascular barrier–enhancing sphingolipid. Because CS has been shown to affect CFTR function, we hypothesized that CFTR function contributes to lung endothelial cell barrier and that CFTR dysfunction worsens CS‐induced injury. CFTR inhibitors GlyH‐101 or CFTRinh172 caused a dose‐dependent increase in pulmonary or bronchial endothelial monolayer permeability, which peaked after 4 hours. CFTR inhibition was associated with both intercellular gaps and actin stress fiber formation compared with vehicle‐treated cells. Increasing endothelial S1P, either by exogenous treatment or by inhibition of its degradation, significantly improved the barrier function in CFTR‐inhibited monolayers. Both cultured lung endothelia and the lung microcirculation visualized in vivo with intravital two‐photon imaging of transgenic mice deficient in CFTR showed that CFTR dysfunction increased susceptibility to CS‐induced permeability. These results suggested that CFTR function might be required for lung endothelial barrier, including adherence junction stability. Loss of CFTR function, especially concomitant to CS exposure, might promote lung inflammation by increasing endothelial cell permeability, which could be ameliorated by S1P.